These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 30498168

  • 1. Clinical Significance of the Floral Shift in Candidiasis.
    Raj AT, Patil S, Sujatha G, Seetharam C, Kader NA.
    J Contemp Dent Pract; 2018 Oct 01; 19(10):1161-1162. PubMed ID: 30498168
    [No Abstract] [Full Text] [Related]

  • 2. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A, Kouzmanov A, Ivanova Z, Zisova L, Amalie G, Petleshkova P, Miteva-Katrandzhieva T, Krasteva M, Uchikova E.
    Akush Ginekol (Sofiia); 2016 Oct 01; 55(4):20-29. PubMed ID: 29370489
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients.
    Hrabovský V, Takáčová V, Schréterová E, Pastvová L, Hrabovská Z, Čurová K, Siegfried L.
    Folia Microbiol (Praha); 2017 Nov 01; 62(6):525-530. PubMed ID: 28361459
    [Abstract] [Full Text] [Related]

  • 9. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
    Schmalreck AF, Willinger B, Haase G, Blum G, Lass-Flörl C, Fegeler W, Becker K, Antifungal Susceptibility Testing-AFST Study Group.
    Mycoses; 2012 May 01; 55(3):e124-37. PubMed ID: 22233267
    [Abstract] [Full Text] [Related]

  • 10. The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.
    Kooshki P, Rezaei-Matehkolaei A, Mahmoudabadi AZ.
    J Mycol Med; 2018 Jun 01; 28(2):340-344. PubMed ID: 29530715
    [Abstract] [Full Text] [Related]

  • 11. Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis.
    Rautemaa R, Richardson M, Pfaller MA, Perheentupa J, Saxén H.
    Diagn Microbiol Infect Dis; 2008 Oct 01; 62(2):182-5. PubMed ID: 18597968
    [Abstract] [Full Text] [Related]

  • 12. Relevance of antifungal penetration in biofilm-associated resistance of Candida albicans and non-albicans Candida species.
    Singh R, Kumari A, Kaur K, Sethi P, Chakrabarti A.
    J Med Microbiol; 2018 Jul 01; 67(7):922-926. PubMed ID: 29767615
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan.
    Tasneem U, Siddiqui MT, Faryal R, Shah AA.
    J Pak Med Assoc; 2017 Jul 01; 67(7):986-991. PubMed ID: 28770873
    [Abstract] [Full Text] [Related]

  • 14. Stable phenotypic resistance of Candida species to amphotericin B conferred by preexposure to subinhibitory levels of azoles.
    Vazquez JA, Arganoza MT, Boikov D, Yoon S, Sobel JD, Akins RA.
    J Clin Microbiol; 1998 Sep 01; 36(9):2690-5. PubMed ID: 9705415
    [Abstract] [Full Text] [Related]

  • 15. Antifungal susceptibility of 50 Candida isolates from invasive mycoses in Chile.
    Silva V, Alvarado D, Diaz MC.
    Med Mycol; 2004 Jun 01; 42(3):283-5. PubMed ID: 15283244
    [Abstract] [Full Text] [Related]

  • 16. Comparative antifungal susceptibility analysis of Candida albicans versus non-albicans Candida corneal isolates.
    Spierer O, Dugar J, Miller D, OʼBrien TP.
    Cornea; 2015 May 01; 34(5):576-9. PubMed ID: 25826327
    [Abstract] [Full Text] [Related]

  • 17. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA, Castanheira M, Messer SA, Jones RN.
    Mycoses; 2015 Apr 01; 58(4):209-14. PubMed ID: 25727853
    [Abstract] [Full Text] [Related]

  • 18. Trends in antifungal susceptibility among Candida sp. Urinary isolates from 1994 and 1998.
    Baran J, Klauber E, Barczak J, Riederer K, Khatib R.
    J Clin Microbiol; 2000 Feb 01; 38(2):870-1. PubMed ID: 10655402
    [Abstract] [Full Text] [Related]

  • 19. In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
    Di Bonaventura G, Spedicato I, Picciani C, D'Antonio D, Piccolomini R.
    Antimicrob Agents Chemother; 2004 Nov 01; 48(11):4453-6. PubMed ID: 15504881
    [Abstract] [Full Text] [Related]

  • 20. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S, Santos ALS, Roudbary M, Hadighi R, Falahati M, Farahyar S, Khoshmirsafa M, Kalantari S.
    Lett Appl Microbiol; 2018 Oct 01; 67(4):392-399. PubMed ID: 30019443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.